Voyager Therapeutics, Inc. (VYGR) › Capital ExpendituresVoyager Therapeutics, Inc. (VYGR) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2014: $2.99M2015: $1.03M2016: $5.03M2017: $3.98M2018: $4.30M2019: $7.72M2020: $12.10M2021: $1.61M2022: $2.49M2023: $3.26M2024: $3.52M2025: $2.60M$2.60M2014Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$2.60M-26.3%2024$3.52M+8.1%2023$3.26M+30.7%2022$2.49M+54.8%2021$1.61M-86.7%2020$12.10M+56.7%2019$7.72M+79.3%2018$4.30M+8.0%2017$3.98M-20.8%2016$5.03M+388.3%2015$1.03M-65.5%2014$2.99M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share